<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>https://ecency.com</link><image><url>https://ecency.com/logo512.png</url><title>RSS Feed</title><link>https://ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Thu, 04 Jun 2026 08:24:53 GMT</lastBuildDate><atom:link href="https://ecency.com/created/viromed/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[바이로메드 RMAT]]></title><description><![CDATA[이번주에 신청한다고 했으나 했는지 안했는지는 말해줄 수 없답니다 신청에 대해서도 홍보를 하지 않겠다는군요 승인되면 시장에 알리겠답니다 이유없이 바이로메드 크게 하락하는 날 짜증이빠이 용수 이 녀석은 바뀌지 않는 군요]]></description><link>https://ecency.com/@jhkim3378/rmat</link><guid isPermaLink="true">https://ecency.com/@jhkim3378/rmat</guid><category><![CDATA[viromed]]></category><dc:creator><![CDATA[jhkim3378]]></dc:creator><pubDate>Thu, 12 Apr 2018 02:57:51 GMT</pubDate></item><item><title><![CDATA[Short sellers switch to other Kosdaq-listed biotech stocks as Celltrion moves to Kospi]]></title><description><![CDATA[Biotech companies topped the short-selling chart of the secondary board on Feb. 8. About KRW 70.4 billion (USD 64.7 million) worth of Celltrion Healthcare shares, or about 14% of the overall transactions,]]></description><link>https://ecency.com/@neosiki/short-sellers-switch-to-other-kosdaq-listed-biotech-stocks-as-celltrion-moves-to-kospi</link><guid isPermaLink="true">https://ecency.com/@neosiki/short-sellers-switch-to-other-kosdaq-listed-biotech-stocks-as-celltrion-moves-to-kospi</guid><category><![CDATA[celltrion]]></category><dc:creator><![CDATA[neosiki]]></dc:creator><pubDate>Mon, 19 Feb 2018 23:06:00 GMT</pubDate></item></channel></rss>